BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25116228)

  • 21. Second malignancies in patients with neuroblastoma: the effects of risk-based therapy.
    Applebaum MA; Henderson TO; Lee SM; Pinto N; Volchenboum SL; Cohn SL
    Pediatr Blood Cancer; 2015 Jan; 62(1):128-33. PubMed ID: 25251613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
    Rihani R; Bazzeh F; Faqih N; Sultan I
    Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Pukkala E; Weiderpass E; Olsen JH; Tracey E; McBride ML; Brewster DH; Pompe-Kirn V; Tonita JM; Kliewer EV; Chia KS; Jonasson JG; Martos C; Magnani C; Boffetta P
    Eur J Cancer; 2008 Apr; 44(6):830-9. PubMed ID: 18329873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second malignant neoplasms following childhood cancer: a study of a recent cohort (1987-2004) from the childhood cancer registry of the Rhône-Alpes region (ARCERRA) in France.
    Berger C; Trombert-Paviot B; Casagranda L; Mialou V; Frappaz D; Plantaz D; Collardeau-Frachon S; Freycon F
    Pediatr Hematol Oncol; 2011 Aug; 28(5):364-79. PubMed ID: 21736475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapy and Risk of Subsequent Malignant Neoplasms in the Childhood Cancer Survivor Study Cohort.
    Turcotte LM; Liu Q; Yasui Y; Henderson TO; Gibson TM; Leisenring W; Arnold MA; Howell RM; Green DM; Armstrong GT; Robison LL; Neglia JP
    J Clin Oncol; 2019 Dec; 37(34):3310-3319. PubMed ID: 31622130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
    Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
    J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salivary gland second cancer after bone sarcoma treatment.
    Longhi A; Errani C; Gambarotti M; Ferrari C; Kreshak J; Panagopoulos GN; Mavrogenis AF; Donati D
    Eur J Orthop Surg Traumatol; 2015 Oct; 25(7):1201-4. PubMed ID: 26174415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second malignancy risk among pediatric, adolescent, and young adult survivors of fusion-positive and fusion-negative sarcomas: Results from the SEER database, 1992 through 2012.
    Lupo PJ; Brown AL; Hettmer S
    Cancer; 2016 Nov; 122(22):3492-3500. PubMed ID: 27481314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
    Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
    J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second malignancies in patients with Ewing Sarcoma Family of Tumors: A population-based study.
    Sultan I; Rihani R; Hazin R; Rodriguez-Galindo C
    Acta Oncol; 2010; 49(2):237-44. PubMed ID: 20100158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Second malignant neoplasms after primary central nervous system malignancies of childhood and adolescence.
    Devarahally SR; Severson RK; Chuba P; Thomas R; Bhambhani K; Hamre MR
    Pediatr Hematol Oncol; 2003 Dec; 20(8):617-25. PubMed ID: 14578032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
    Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
    JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A; Berrington de Gonzalez A; Curtis RE; Rajaraman P
    Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary malignant neoplasms following radiotherapy for primary cancer in children and young adults.
    Harbron RW; Feltbower RG; Glaser A; Lilley J; Pearce MS
    Pediatr Hematol Oncol; 2014 Apr; 31(3):259-67. PubMed ID: 24087931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and clinical characteristics of second malignant neoplasms in children: a multicenter study of a polish pediatric leukemia/lymphoma group.
    Kowalczyk J; Nurzyńska-Flak J; Armata J; Bogusławska-Jaworska J; Rokicka-Milewska R; Sońta-Jakimczyk D; Balwierz W; Chybicka A; Kaczmarek-Kanold M; Wachowiak J; Matysiak M; Pawelec K
    Med Sci Monit; 2004 Mar; 10(3):CR117-22. PubMed ID: 14976453
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second malignant neoplasms in childhood cancer survivors in a tertiary paediatric oncology centre in Hong Kong, China.
    Sun WF; Cheng FW; Lee V; Leung WK; Shing MK; Yuen PM; Li CK
    Chin Med J (Engl); 2011 Nov; 124(22):3686-92. PubMed ID: 22340225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Second Malignant Neoplasms in Childhood Cancer Survivors Treated in a Tertiary Paediatric Oncology Centre.
    Lim JW; Yeap FS; Chan YH; Yeoh AE; Quah TC; Tan PL
    Ann Acad Med Singap; 2017 Jan; 46(1):11-19. PubMed ID: 28182813
    [No Abstract]   [Full Text] [Related]  

  • 38. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group.
    Breslow NE; Takashima JR; Whitton JA; Moksness J; D'Angio GJ; Green DM
    J Clin Oncol; 1995 Aug; 13(8):1851-9. PubMed ID: 7636528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The epidemiology of osteosarcoma.
    Ottaviani G; Jaffe N
    Cancer Treat Res; 2009; 152():3-13. PubMed ID: 20213383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.